INCYTE CORP's ticker is and the CUSIP is 45337CAN2. A total of 16 filers reported holding INCYTE CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,789,000 | +187.7% | 2,276,000 | +355.2% | 0.01% | +200.0% |
| Q1 2017 | $1,317,000 | -76.8% | 500,000 | -80.8% | 0.00% | -76.5% |
| Q4 2015 | $5,685,000 | -23.1% | 2,605,000 | -23.4% | 0.02% | -22.7% |
| Q3 2015 | $7,397,000 | +78.9% | 3,400,000 | +70.0% | 0.02% | +100.0% |
| Q2 2015 | $4,134,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 22,232,000 | $35,092,000 | 1.94% |
| Nicholas Investment Partners, LP | 3,120,000 | $4,898,000 | 0.36% |
| CSS LLC/IL | 3,500,000 | $5,577,000 | 0.34% |
| Hudson Bay Capital Management LP | 2,500,000 | $3,954,000 | 0.19% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3,937,000 | $6,226,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,402,000 | $2,216,000 | 0.07% |
| Orbimed Advisors | 4,250,000 | $6,727,000 | 0.07% |
| Citadel Advisors | 28,500,000 | $44,936,000 | 0.06% |
| Calamos Advisors LLC | 4,960,000 | $7,851,000 | 0.05% |
| GABELLI FUNDS LLC | 1,000,000 | $1,570,000 | 0.01% |